The authors described that doxorubicin, pazopanib, and temozolomide did not affect the tumor growth, while irinotecan alone or in combination with temozolomide, or in combination with cisplatinum, decreased tumor growth. S. typhimuriom also arrested the growth of the tumor [91]. Conclusions and ...